19-12799911-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005809.6(PRDX2):c.459T>G(p.Asp153Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000577 in 1,613,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005809.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDX2 | NM_005809.6 | c.459T>G | p.Asp153Glu | missense_variant | 5/6 | ENST00000301522.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDX2 | ENST00000301522.3 | c.459T>G | p.Asp153Glu | missense_variant | 5/6 | 1 | NM_005809.6 | P1 | |
ENST00000585496.1 | n.201-1843A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.000592 AC: 90AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000545 AC: 137AN: 251400Hom.: 0 AF XY: 0.000559 AC XY: 76AN XY: 135888
GnomAD4 exome AF: 0.000575 AC: 841AN: 1461558Hom.: 1 Cov.: 31 AF XY: 0.000579 AC XY: 421AN XY: 727076
GnomAD4 genome ? AF: 0.000591 AC: 90AN: 152260Hom.: 0 Cov.: 31 AF XY: 0.000564 AC XY: 42AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.459T>G (p.D153E) alteration is located in exon 5 (coding exon 4) of the PRDX2 gene. This alteration results from a T to G substitution at nucleotide position 459, causing the aspartic acid (D) at amino acid position 153 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at